nadunolimab,NV354
cantargia,Abliva
['nadunolimab', 'pancreatic', 'cantargia']
abliva $abli drug candidate nv354 granted orphan drug designation for the treatment of mitochondrial disease cantargia $canta presents new clinical data at aacr 2023 strongly supporting nadunolimab development in pancreatic cancer 
Business Intelligence on European listed biotech companies
Subscription Plan now available for retail customers